PHARMXPERTISE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMXPERTISE
Largest movements
- Current investments -€21,432
down €21,432 (-32.2%), from €66,484 to €45,052
- Cash +€20,781
up €20,781 (+198%), from €10,476 to €31,258
mainly Current investments (+€21,432) and Net result for the year (+€19,228)
- Receivables within one year -€12,364
down €12,364 (-47.0%), from €26,293 to €13,929
of which Trade receivables: -€9,966
- Tangible fixed assets -€10,881
down €10,881 (-10.2%), from €106,486 to €95,604
of which Leasing and similar rights: -€8,048
- Other debts -€35,120
down €35,120 (-87.8%), from €40,000 to €4,880
- Profit (loss) carried forward +€19,228
up €19,228 (+14.5%), from €132,914 to €152,143
- Debts after one year -€7,322
down €7,322 (-32.5%), from €22,519 to €15,197
- Tax, wage and social debts -€2,610
down €2,610 (-97.9%), from €2,667 to €57
of which Taxes: -€2,610
- Write-downs +€23,400
new in 2025: €23,400
- Gross operating margin +€15,012
up €15,012 (+32.2%), from €46,691 to €61,703
- Financial income +€6,538
up €6,538 (+6,145%), from €106 to €6,644
- Depreciation +€1,103
up €1,103 (+7.4%), from €14,915 to €16,018
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €211,275 | €186,806 | -€24,469 | -11.6% |
| Fixed assets | 21/28 | €106,486 | €95,604 | -€10,881 | -10.2% |
| Tangible fixed assets | 22/27 | €106,486 | €95,604 | -€10,881 | -10.2% |
| Furniture and vehicles | 24 | €16,221 | €18,372 | +€2,151 | +13.3% |
| Leasing and similar rights | 25 | €30,251 | €22,203 | -€8,048 | -26.6% |
| Other tangible fixed assets | 26 | €60,013 | €55,029 | -€4,984 | -8.3% |
| Current assets | 29/58 | €104,789 | €91,202 | -€13,588 | -13.0% |
| Amounts receivable within one year | 40/41 | €26,293 | €13,929 | -€12,364 | -47.0% |
| Trade receivables | 40 | €16,629 | €6,664 | -€9,966 | -59.9% |
| Other amounts receivable | 41 | €9,664 | €7,265 | -€2,399 | -24.8% |
| Current investments | 50/53 | €66,484 | €45,052 | -€21,432 | -32.2% |
| Cash at bank and in hand | 54/58 | €10,476 | €31,258 | +€20,781 | +198% |
| Deferred charges and accrued income | 490/1 | €1,536 | €964 | -€572 | -37.3% |
| Total equity and liabilities | 10/49 | €211,275 | €186,806 | -€24,469 | -11.6% |
| Equity | 10/15 | €135,914 | €155,143 | +€19,228 | +14.1% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €132,914 | €152,143 | +€19,228 | +14.5% |
| Amounts payable | 17/49 | €75,361 | €31,663 | -€43,697 | -58.0% |
| Amounts payable after more than one year | 17 | €22,519 | €15,197 | -€7,322 | -32.5% |
| Financial debts | 170/4 | €22,519 | €15,197 | -€7,322 | -32.5% |
| Amounts payable within one year | 42/48 | €52,842 | €16,466 | -€36,375 | -68.8% |
| Current portion of amounts payable after more than one year | 42 | €7,017 | €7,322 | +€305 | +4.3% |
| Trade debts | 44 | €3,158 | €4,207 | +€1,049 | +33.2% |
| Suppliers | 440/4 | €3,158 | €4,207 | +€1,049 | +33.2% |
| Taxes, remuneration and social security | 45 | €2,667 | €57 | -€2,610 | -97.9% |
| Taxes | 450/3 | €2,667 | €57 | -€2,610 | -97.9% |
| Remuneration and social security | 454/9 | €0 | €0 | = | |
| Other amounts payable | 47/48 | €40,000 | €4,880 | -€35,120 | -87.8% |
| Remuneration, social security and pensions | 62 | €0 | €0 | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,915 | €16,018 | +€1,103 | +7.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €23,400 | +€23,400 | |
| Other operating charges | 640/8 | €488 | €686 | +€198 | +40.5% |
| Gross operating margin | 9900 | €46,691 | €61,703 | +€15,012 | +32.2% |
| Operating profit (loss) | 9901 | €31,288 | €21,599 | -€9,689 | -31.0% |
| Financial income | 75/76B | €106 | €6,644 | +€6,538 | +6,145% |
| Recurring financial income | 75 | €106 | €6,644 | +€6,538 | +6,145% |
| Financial charges | 65/66B | €1,650 | €1,201 | -€449 | -27.2% |
| Recurring financial charges | 65 | €1,650 | €1,201 | -€449 | -27.2% |
| Profit (loss) for the period before taxes | 9903 | €29,744 | €27,043 | -€2,702 | -9.1% |
| Income taxes | 67/77 | €8,026 | €7,814 | -€212 | -2.6% |
| Profit (loss) for the period | 9904 | €21,718 | €19,228 | -€2,490 | -11.5% |
| Profit (loss) for the period to be appropriated | 9905 | €21,718 | €19,228 | -€2,490 | -11.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.